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Summary
Background
The metabolic syndrome (MetS) is a complication to overweight and obesity, which can
be observed already in childhood. Ectopic lipid accumulation in muscle and liver has
been shown to associate with the development of insulin resistance and dyslipidemia.
Thus, the interaction between MetS and ectopic fat may offer clinical relevance.
Objectives
To investigate the prevalence of MetS, or components hereof, and ectopic fat accumula-
tion in liver and skeletal muscle tissue in children, as well as interactions between these.
Methods
Two-hundred-and-sixteen children and adolescents (95 boys) with overweight/obesity
were investigated, as well as 47 controls (22 boys) with normal weight. The assessments
included anthropometry, fasting blood biochemistry and blood pressure measurements.
Liver and muscle lipid contents were assessed by proton magnetic resonance
spectroscopy.
Results
We observed an odds ratio in girls with overweight/obesity of 12.2 (95% confidence in-
terval: [3.8; 49.0]) for exhibiting MetS when hepatic steatosis was present, whereas no
association was observed in boys with overweight/obesity (odds ratio 0.7 [0.2; 2.7]).
The odds ratio of exhibiting MetS in the presence of muscular steatosis was 3.5 [1.4;
9.5] in girls with overweight/obesity and 1.0 [0.2; 5.6] in boys with overweight/obesity.
Similar results were seen for girls with overweight/obesity exhibiting concurrent hepatic
and muscular steatoses.
Conclusion
Hepatic and muscular steatoses were associated with MetS among girls, but not among
boys with overweight/obesity.
Keywords: Ectopic fat, metabolic syndrome X, obesity, paediatrics.
Introduction
Obesity among children and adolescents is a health chal-
lenge worldwide (1–3). Childhood obesity is associated
with an increased risk of developing a variety of
comorbidities (4–8), including the metabolic syndrome
(MetS) which is often defined as the presence of at least
three of the following components: Abdominal obesity,
dyslipidemia, hypertension and impaired glucose toler-
ance (7,9). The presence of MetS in adults is a known risk
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factor for later development of cardiovascular disease
and type 2 diabetes mellitus (10).
However, not all children and adolescents with obesity
develop MetS (11). The development of MetS is related to
the lipid distribution within the body and the proportion of
lipids deposited as ectopic fat (12,13), which in turn may
be associated with insulin resistance (14,15).
Ectopic fat is the presence of lipids in organs that are
not primary physiological sites for lipid storage, including
the liver and skeletal muscle tissues. Ectopic fat can al-
ready manifest in childhood (16–18), and to a greater ex-
tent in children with overweight and obesity than in
children with normal weight (4,18–20). Further, some
studies indicate that boys with overweight/obesity may
have a greater tendency to accumulate fat as ectopic fat
in the liver as compared to girls with overweight/obesity
(18,21–23).
The relationship between the components of MetS and
ectopic fat accumulation has previously been reported in
children and adolescents with obesity, showing that he-
patic steatosis is associated with higher body mass index
(BMI) (18,24), dyslipidemia (14), fasting hyperinsulinemia
(23,24) and impaired glucose tolerance (21). Likewise, in-
sulin sensitivity has been shown inversely correlated to
intramyocellular lipid content (15). Further, correlations
between impaired glucose tolerance and muscle fat con-
tent (MFC) have been observed (25).
In a recent study from our group (18), the relationships
between ectopic fat and measures of insulin resistance,
dyslipidemia and anthropometric data were examined in
a group of children and adolescents with overweight
and obesity.
In the present study, we wanted to explore these data
further by analysing the relationships between MetS in
its entirety and ectopic fat in liver and muscle, and to elu-
cidate whether observed sex differences regarding ec-
topic fat deposition would translate into differentiated
risk profiles regarding the development of MetS.
Methods
Study population
The study population consisted of 221 children and
adolescents (98 boys) with overweight/obesity enrolled
in a tertiary multidisciplinary childhood obesity treatment
programme (26) in the period between August 2009 and
August 2014. The participants had a magnetic resonance
spectroscopy (MRS) assessment of ectopic lipid accu-
mulation in liver and/or skeletal muscle within 60 days of
anthropometric measures in the clinic, and estimates
ofׄfasting plasma glucose and lipids. The inclusion
criteria were a BMI standard deviation score (SDS) above
1.28 for age and sex according to Danish reference
charts (27) and an age between 6 and 22 years. The ex-
clusion criteria were inability to lie still for 45min in the
magnetic resonance (MR) scanner or a body weight
above 135 kg (thereby exceeding the maximum capacity
of the MR scanner).
The control group consisted of 47 children and adoles-
cents with normal weight (22 boys) recruited from local
schools in the period between April 2012 and August
2014. The inclusion criteria for the control group were a
BMI SDS below 1.2 and an age between 6 and 22 years
and the exclusion criteria were identical to those of the
study group.
Informed written and oral consents were obtained from
parents or participants aged 18 years or older. The study
was approved by the Ethics Committee of Region
Zealand, Denmark (protocol no. SJ-104) and was con-
ducted in accordance with the Helsinki Declaration.
Definition of the metabolic syndrome
In this study, MetS was defined according to a modified
version of the International Diabetes Federation criteria
(28). In the International Diabetes Federation’s version,
age- and sex-matched reference values are used for
waist circumference (WC), whereas absolute cut-off
values are used for systolic blood pressure (SBP), dia-
stolic blood pressure (DBP), fasting plasma triglycerides,
fasting plasma high-density lipoprotein (HDL) cholesterol
and fasting plasma glucose (28). We moderated this ver-
sion by applying cut-off values for SBP and DBP accord-
ing to age-, height- and sex-matched reference values
(29), as we considered these more appropriate in a paedi-
atric population because of changes during growth and
development. Further, we used a German reference pop-
ulation for the WC (30,31), as we found this study material
to be comparable with our study population. Hence, our
definition of MetS was:
□ WC above the 90th percentile on age- and sex-
matched reference curves (30,31), and two or
more of the following:
□ SBP and/or DBP above or equal to the 95th per-
centile for age, height and sex (29)
□ Fasting plasma triglycerides above or equal to
1.7mmol/L (150mg/dL)
□ Fasting plasmaHDLbelow1.03mmol/L (40mg/dL)
□ Fasting plasma glucose above or equal to
5.6mmol/L (100mg/dL)
A MetS score was calculated based on the presence of
the above-mentioned components of MetS: Fulfilling the
WC criteria was scored 3 points, whereas each of the
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other components was scored 1 point. Children with a
MetS score of 5 or more had by definition MetS.
Anthropometric measures
Weight was measured to the nearest 0.1 kg on a Tanita®
digital medical scale, WB-110 MA (Tanita Corp., Tokyo,
Japan), while wearing light indoor clothing with empty
pockets and no shoes. Height was measured to the
nearest 1mm with a stadiometer. BMI was calculated as
weight divided by height squared (kg/m2). The BMI SDS
was calculated by the LMS method by converting BMI
into a normal distribution by sex and age using the me-
dian coefficient of variation and a measure of the skew-
ness (32), based on the Box–Cox power plot based on
Danish BMI charts (27).
WC was measured at the level of the umbilicus to the
nearest 1mm with a non-elastic tape measure. The mea-
surement was performed with the child in standing posi-
tion, with the arms down and post-exhalation.
Pubertal developmental stages were evaluated ac-
cording to the methods of Tanner (33,34); children and
adolescents with overweight/obesity were clinically eval-
uated by a paediatrician, whereas the controls self-
reported by picture pattern recognition supplemented by
a detailed written explanation.
Blood pressure
Blood pressure was measured after 5min of rest in the
supine position. The measurement was repeated three
times, and the average of the second and third measure-
ments was used. The blood pressure values were com-
pared to the distribution in an American reference
population (29), and blood pressure SDS was calculated
according to the guidelines from the European Society
of Hypertension (35).
Until 10 June 2011, blood pressure was measured
manually on the right arm by an aneroid sphygmomanom-
eter (MaxiStabil3 ®, Speidel & Keller, Welch Allyn inc.,
New York, USA) using the auscultatory method in a total
of 50 cases. After 10 June 2011, in a total of 166 cases
and 47 controls, blood pressure was measured with an
electronic sphygmomanometer (Omron 705IT ®, Omron
Healthcare Co. Ltd., Kyoto, Japan). The device has been
validated for use in children and adolescents who are nor-
motensive (36), and no significant difference was found
comparing measurements performed by the device to
manually measured blood pressure in 197 children (36).
Blood samples
Blood samples were collected after an overnight fast be-
tween 7 and 9 am by venipuncture of the antecubital vein.
If necessary, a local anaesthetic cream (lidocain/prilocain
mixture, EMLA®, AstraZeneca, Sweden) was applied 1 h
prior to the venipuncture.
Fasting blood samples of serum triglycerides, serum
HDL cholesterol and plasma glucose were stored at room
temperature for less than 30min after sampling before
being centrifuged at 4 °C and then immediately analysed
on a Siemens Dimension Vista® 1500 analyser (Siemens
AG, Munich, Germany). Blood samples for analysis of
plasma glucose were collected in fluoride containing
tubes.
Magnetic resonance spectroscopy
Hepatic and muscular fat content measurements were
obtained by MRS. The MRS scans were performed by
trained personnel using an Achieva 3.0 T MR imaging sys-
tem (Philips Medical Systems, Best, the Netherlands). The
cut-off value for liver steatosis was set as a 5% or higher
content of macrovesicular fat in the hepatocytes as sug-
gested by Schwimmer et al. (37). Further details on the
method for measuring liver fat content have previously
been described by Bille et al. (16).
MFC was measured in the psoas major muscle. The
cut-off value for muscular steatosis was defined as a
MFC of 5% or more as suggested by Fonvig et al. (17).
Details on the measurements of MFC have previously
been described by Fonvig et al. (17,18).
Statistical analysis
In Table 1, the Wilcoxon signed rank test was used for
group comparisons in the continuous variables, while
Fisher’s exact test was used for analysing differences in
categorical data. In Tables 2 and 3, multiple linear
regression models adjusted for age and pubertal
developmental stage were used for the association anal-
yses where the ectopic fat content was used as the
independent variable in all analyses except for WC. In
analyses of the population stratified by age, differences
across groups of continuous variables were evaluated
by the analyses of variance (ANOVA) test, and the
categorical variables were evaluated by Pearson’s
Chi-squared test.
Odds ratios (OR) were analysed using multiple logis-
tic regression analyses adjusted for age and pubertal
developmental stage. The level of significance was set
at p< 0.05. P-values were not adjusted for multiple hy-
pothesis testing. The statistical analyses were performed
in R statistical software, version 3.1.2 (http://www.r-pro-
ject.org).
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Results
Five patients were excluded from the study because of a
body weight above 135 kg. The eligible 216 children and
adolescents (95 boys) with overweight/obesity had a me-
dian BMI SDS of 2.91 (range: 1.49; 5.80) and a median
age of 12.9 years (7.8; 20.4), and the 47 (22 boys) children
and adolescents with normal weight had a median BMI
SDS of 0.00 (1.23; 1.18) and a median age of 14.8
(9.0; 20.7). Baseline characteristics of the children and
adolescents with overweight/obesity and the control chil-
dren are shown in Table 1.
The girls and boys with overweight/obesity had a
higher prevalence of MetS compared to the controls
(girls: 40% vs. 0%, p< 0.001; boys: 41% vs. 0%
p< 0.001), a higher prevalence of hepatic steatosis (girls:
Table 1 Baseline characteristics of the 216 children and adolescents with overweight/obesity and the 47 children and adolescents with normal
weight. Data are given as medians (with ranges), unless otherwise stated. The Wilcoxon signed rank test was used for group comparisons in the
continuous variables, while Fisher’s exact test was used for analysing differences in categorical data
Overweight/
Obese ♀ Controls ♀ P
Overweight/
Obese ♂ Controls ♂ P
P Overweight/
Obese ♀ versus ♂
P Controls
♀ versus ♂
N 121 25 95 22
Age, years 13.4 (7.8; 20.4) 16.0 (10.9;20.7) 0.002 12.6 (8.3;18.0) 14.0 (9.0;18.9) 0.19 0.24 0.07
BMI SDS 2.73 (1.5;4.1) 0.06 (1.2;1.2) <0.001 3.2 (1.6;5.8) 0.25 (1.2;1.0) <0.001 <0.001 0.81
WC, cm 94.0 (59.0;137.0) 68.0 (61.5;78.5) <0.001 98.5 (77.0;145.0) 71.0 (60.0;82.0) <0.001 0.005 0.31
HDL mmol/L 1.1 (0.6;2.1) 1.6 (1.1;2.1) <0.001 1.2 (0.4;2.2) 1.8 (0.8;2.3) <0.001 0.38 0.32
TG mmol/L 1.0 (0.4;4.1) 0.7 (0.4;1.9) 0.003 0.9 (0.2;3.9) 0.5 (0.3;0.9) <0.001 0.13 0.006
fPG mmol/L 4.9 (3.4;6.3) 5.0 (4.3;6.0) 0.20 5.2 (4.1;6.2) 5.2 (4.1;5.7) 0.14 <0.001 0.81
SBP SDS 2.3 (2.2;5.6) 1.7 (0.1;4.4) 0.06 2.1 (0.4;5.3) 2.5 (0.3;4.8) 0.66 0.33 0.16
DBP SDS 1.0 (1.5;3.4) 0.4 (0.1;1.5) 0.002 0.7 (0.8;2.5) 0.7 (0.7;1.5) 0.78 0.003 0.74
Tanner stage
P 4.0 (1.0;5.0) 5.0 (1.0;5.0) 1.00 2.0 (1.0;5.0) 2 (1;5) 0.50 <0.001 0.32
B, ♀ 4.0 (1.0;5.0) 4.5 (1.0;5.0) 0.44 <0.001 0.25
G, ♂ 2.0 (1.0;5.0) 4.0 (1.0;5.0) 0.24
LFC, % 3.0 (0.5;32.8) 1.5 (1.0;6.0) <0.001 3.0 (1.0;75.9) 1.5 (1.0;3.0) <0.001 0.002 0.55
Hepatic steatosis
fraction, %
23 (28/121) 4 (1/25) 0.03 38 (36/95) 0 (0/22) <0.001 0.02 1.00
MFC*, % 7.3 (0.6;46.7) 2.6 (0.4;8.7) <0.001 7.3 (1.0;36.8) 1.0 (0.5;8.3) <0.001 0.34 0.32
Muscular steatosis
fraction*, %
67 (74/110) 22 (5/23) <0.001 66 (51/77) 10 (2/21) <0.001 1.00 0.42
*nobese girls = 110, nlean girls = 23, nobese boys = 77, nlean boys = 21.
B, breast stage; BMI, body mass index; DBP, diastolic blood pressure; fPG, fasting plasma glucose; G, genital stage; HDL, high density lipopro-
tein; LFC, liver fat content; MetS, metabolic syndrome; MFC, muscular fat content; P, pubic hair; SBP, systolic blood pressure; SDS, standard
deviation score; TG, triglycerides; WC, waist circumference; Bold, p< 0.05.
Table 2 Multiple linear regression analyses of components of the metabolic syndrome and hepatic fat in the 121 girls and 95 boys with over-
weight/obesity. Estimates ± standard deviation (Est ± SD), correlations coefficients (R2) of the relationships between metabolic syndrome (MetS)
score or MetS components and liver fat content. The analyses were adjusted for age and pubertal developmental stage. The MetS score was
calculated based on the number of components fulfilled, where fulfilling the WC criteria was scored 3 points, and each of the other components
was scored 1 point
Girls Boys
Est ± SD P R2 Est ± SD P R2
MetS score 0.08 ± 0.02 0.001 0.15 0.00 ± 0.01 0.49 0.35
WC cm 0.18 ± 0.04 <0.001 0.18 0.36 ± 0.16 0.03 0.26
TG, mmol/L 0.03 ± 0.01 0.01 0.07 0.00 ± 0.01 0.78 0.20
HDL, mmol/L 0.01 ± 0.00 0.05 0.06 0.00 ± 0.00 0.10 0.24
fPG, mmol/L 0.02 ± 0.01 0.008 0.09 0.00 ± 0.00 0.71 0.11
SBP SDS 0.01 ± 0.02 0.76 0.27 0.00 ± 0.00 0.64 0.49
DBP SDS 0.01 ± 0.01 0.68 0.17 0.00 ± 0.001 0.36 0.26
BMI, body mass index; DBP, diastolic blood pressure; fPG, fasting plasma glucose; HDL, high density lipoprotein; SBP, systolic blood pressure;
SDS, standard deviation score; TG, triglycerides; WC, waist circumference. Bold, p< 0.05.
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23% vs. 4%, p=0.03; boys: 38% vs. 0% p< 0.001) and
of muscular steatosis (girls: 61% vs. 22 %, p<0.001;
boys: 66% vs. 10%, p< 0.001) (Table 1). Muscle fat mea-
surement was available in 187 children and adolescents
(77 boys) with overweight/obesity, and 44 of the controls
(21 boys).
Tables 2 and 3 show the results of the multiple regres-
sion analyses including the associations between each of
the components of MetS, as well as the MetS score, and
hepatic fat content (Table 2) respectively muscular fat
content (Table 3) in the group of children and adolescents
with overweight/obesity. The analyses were adjusted for
age and pubertal development.
In order to evaluate the influence of age on the
relationship between MetS and ectopic fat accumula-
tion, the part of the population with overweight/obesity
were stratified by age, resulting in a group of children
(7.8–13.0 years old, n=111), a group of adolescents
(13.0–18.0 years old, n=101) and a group of adults
(18.1–20.4 years old, n=4). When comparing the groups
regarding the presence of MetS and components hereof
and hepatic or muscular steatosis, the groups were
significantly different in MetS score, with the children
having a lower score than the adolescents and
adults (p=0.002), mean WC (children 91.7 cm,
adolescents 103.2 cm, adults 126 cm, p< 0.001), mean
HDL cholesterol (children 1.23mmol/L, adolescents
1.12mmol/L, adults 1.27mmol/L, p=0.019), mean SBP
z-score (children 1.67, adolescents 2.85, adults 4.25,
p< 0.001), mean DBP z-score (children 0.71, adolescents
1.1, adults 2.24, p< 0.001) and presence of MetS
(children 29.7%, adolescents 52.5%, adults 50%,
p=0.003).
Regression analyses were performed in the groups of
children and adolescents only, as the adult group was
too small in number. In the girls in the children group,
we observed a positive association between liver fat and
WC (p<0.001), whereas for the girls in the adolescent
group, we observed a positive association between liver
fat and MetS score (p=0.01), triglycerides (p=0.003),
fasting plasma glucose (p< 0.001) and SBP (p=0.045).
In the boys in the children group, we observed no signifi-
cant associations between liver fat and MetS score or
components of MetS. In the boys in the adolescent
group, we observed a positive association between liver
fat and WC (p=0.04).
In younger girls, we observed a positive association
between muscle fat and MetS score (p=0.049), WC
(p=0.026) and DBP (p=0.018), whereas in the older girls
we observed a positive association between fasting
plasma glucose (p=0.03) and SBP (p=0.02). In boys,
there were no significant associations between muscle
fat and MetS score or components of MetS in neither
age group.
The presence of hepatic steatosis in girls with
overweight/obesity was associated with an increased
risk of having MetS with an OR of 12.2 (95% confidence
interval (CI): [3.8; 49.0], p< 0.001). In boys with
overweight/obesity, no significant association was found
between hepatic steatosis and the risk of having MetS
(OR 0.7, 95% CI: [0.2; 2.7], p=0.61) (Table 4).
Muscular steatosis was associated with an increased
risk of having MetS in girls with overweight/obesity (OR
3.5; 95% CI: [1.4; 9.5]; p=0.009), but not in boys with
overweight/obesity (OR 1.0; 95% CI: [0.2; 5.6]; p=0.96)
(Table 4).
Finally, concomitant hepatic and muscular steatosis
was significantly associated with an increased OR of hav-
ing MetS in girls with overweight/obesity (OR 31.4; 95%
CI: [6.4; 205.9]; p< 0.001), but not in boys with
overweight/obesity (OR 0.8; 95% CI: [0.1; 9.7]; p=0.88)
(Table 4).
Table 3 Multiple linear regression analyses of components of the metabolic syndrome and muscular fat in the 110 girls and 77 boys with over-
weight/obesity. Estimates ± standard deviation (Est ± SD), correlations coefficients (R2) of the relationships between metabolic syndrome (MetS)
score or MetS components and muscle fat content. The analyses were adjusted for age and pubertal developmental stage. The MetS score was
calculated based on the number of components fulfilled, where fulfilling the WC criteria was scored 3 points, and each of the other components
was scored 1 point
Girls Boys
Est ± SD P R2 Est ± SD P R2
MetS score 0.04 ± 0.02 0.046 0.10 0.01 ± 0.012 0.60 0.34
WC, cm 0.09 ± 0.05 0.10 0.09 0.02 ± 0.08 0.80 0.06
TG, mmol/L 0.01 ± 0.01 0.20 0.03 0.01 ± 0.02 0.56 0.28
HDL, mmol/L 0.01 ± 0.01 0.10 0.06 0.00 ± 0.01 0.66 0.26
fPG, mmol/L 0.01 ± 0.01 0.21 0.04 0.01 ± 0.01 0.34 0.10
SBP SDS 0.02 ± 0.02 0.18 0.28 0.00 ± 0.03 0.93 0.39
DBP SDS 0.00 ± 0.01 0.75 0.20 0.00 ± 0.02 0.74 0.10
BMI, body mass index; DBP, diastolic blood pressure; fPG, fasting plasma glucose; HDL, high density lipoprotein; SBP, systolic blood pressure;
SDS, standard deviation score; TG, triglycerides; WC, waist circumference. Bold, p< 0.05.
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When stratifying the analyses of Table 4 for age, we ob-
served comparable results, except that in the girls in the
children group we did not observe a significant associa-
tion between muscular steatosis and MetS (p=0.065).
Discussion
In the present study, we found a higher prevalence of
MetS, liver steatosis and muscular steatosis in girls and
boys with overweight/obesity when compared to children
with normal weight. The high prevalence rates of MetS,
liver steatosis and muscular steatosis in the children and
adolescents with overweight/obesity were expected con-
sidering obesity as a known risk factor of development of
both MetS and ectopic fat accumulation (5,7,19).
The comparable prevalence rates of MetS between the
sexes in our study are in contrast to the recently reported
European IDEFICS study (38), which included 18,169 chil-
dren (2,606 with overweight or obesity). In that study, four
different definitions of MetS were applied, and three of the
definitions showed that MetS prevalence rates were
higher among girls with obesity as compared to boys with
obesity. However, in the IDEFICS study slightly other def-
initions of MetS than the one applied in this study were
applied, which may explain the different findings in the
prevalence of MetS. In a study by Cook et al., several of
the most commonly used definitions of MetS were ap-
plied in analyses of a group of adolescents with obesity,
and the prevalence rates varied from 12.4% to 44.2%
(11), suggesting that the results are dependent on the ap-
plied MetS definition. To date, there is no international
consensus on the preferable definition of MetS in children
and adolescents (11,38).
The difference in prevalence rates of hepatic steatosis
between girls and boys with overweight/obesity found in
this study is in line with previous studies (21–23). The
higher prevalence of muscular steatosis in children with
overweight/obesity as compared to the controls is also
similar to previous findings (39).
Interestingly, the MetS score and some components of
the MetS were associated to the liver fat content in the
girls with overweight/obesity, whereas in the boys with
overweight/obesity, only WC showed an association with
liver fat content. Similarly, the association between
hepatic steatosis and MetS was only significant in girls
with overweight/obesity, while not in boys with
overweight/obesity.
These findings are in line with some of the previously
reported associations between hepatic steatosis and
MetS in children with overweight/obesity (8,14), although
in those studies the potential influence from sex differ-
ences was not examined.
In a community-based cohort of 1,170 adolescents,
Ayonrinde et al. (40) showed a higher prevalence of non-
alcoholic fatty liver disease (NAFLD) in boys as compared
to the girls with obesity, which support findings from the
present study, whereas MetS was more prevalent in boys
as compared to girls with NAFLD, which is in contrast to
the results of the present study.
Unfortunately, that study (40) did not evaluate the MetS
prevalence stratified by obesity. These results may differ
from the present study because of the community-based
– and not an obesity-based – cohort or because liver
steatosis was assessed by ultrasound and not MRS,
which has previously been shown to be less accurate
than MRS in diagnosing hepatic steatosis (41).
Other studies have shown associations between he-
patic steatosis and MetS in boys, but not in girls (42,43).
However, in these studies the diagnosis of NAFLD was
based on elevated levels of alanine aminotransferase
(ALT), which have shown to correlate poorly with the ac-
tual liver fat content as compared to measures obtained
by ultrasound, MRS or even liver biopsies (14,40,44,45).
In a study of 134 adolescents by Rehm et al. (45), the re-
lationship between ALT concentrations and magnetic res-
onance imaging-diagnosed hepatic steatosis was
analysed. They found that, with an ALT cut-off value at
65 U/L, the sensitivity for predicting hepatic steatosis
was only 9% (20 out of 22 with hepatic steatosis did not
have ALT concentrations above 65 U/L) and the specific-
ity was 100%. Therefore, we find it difficult to compare
our results to the results in those studies (42,43), as we
would have underestimated the prevalence of hepatic
steatosis if diagnosed by ALT concentrations. Finally, a
study by Cicero et al. (46) showed associations between
indices of hepatic steatosis and MetS in both men and
Table 4 Logistic regression analyses of having MetS when either hepatic steatosis (n = 216, 95 boys), muscular steatosis (n = 187, 77 boys) or
both (as compared to no steatosis) are present in the girls and boys with overweight/obesity. The analyses are adjusted for age and pubertal de-
velopmental stage. The results are given as odds ratios (OR) with 95% confidence intervals ([CI95%])
Girls Boys
OR [CI95%] P OR [CI95%] P
Hepatic steatosis 12.2 [3.8; 49.0] <0.001 0.7 [0.2; 2.7] 0.61
Muscular steatosis 3.5 [1.4; 9.5] 0.009 1.0 [0.2; 5.6] 0.96
Both 31.4 [6.4; 205.9] <0.001 0.8 [0.1; 9.7] 0.88
Bold, p< 0.05.
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women; however, these indices were also based on ALT
levels, which as argued limits comparability between the
studies.
Knowledge is sparse in regards to the association be-
tween MetS and muscular steatosis in children and ado-
lescents with overweight/obesity. We found that MetS
score associated to MFC in girls with overweight/obesity
and that the risk of MetS was greater in girls with over-
weight/obesity and exhibiting muscular steatosis,
whereas no such association was seen in the boys with
overweight/obesity. In a study by Cali and Caprio (5) of
89 children and adolescents with overweight/obesity, an
increased prevalence of MetS was associated with in-
creasing amount of visceral fat, whereas no association
was found between increasing visceral fat and increasing
intramyocellular fat content. These findings imply a lack of
association between intramyocellular fat content and
MetS, as in contrast to the present study. In the study
by Cali and Caprio (5), the study population was not strat-
ified by sex, which might have masked an association be-
tween MetS and muscular steatosis in girls as seen in the
present study, and further, different MetS definitions were
applied which also impedes comparison between the two
studies.
Altogether, the present study shows, that the risk of ac-
cumulating ectopic fat in boys with overweight/obesity,
whether being in the liver, the muscle, or both, is not as-
sociated with the presence of MetS, as in opposition to
what was found in girls with overweight/obesity, despite
a higher prevalence of hepatic steatosis among the boys.
This may indicate that boys may have a risk of accumulat-
ing liver fat independent from their risk of developing
MetS.
A possible explanation for the findings might be a
smaller capacity to store fat as subcutaneous adipose tis-
sue in boys compared to girls and/or a greater tendency
to store fat as visceral fat, as a result of differences in cir-
culating levels of sex steroids and glucocorticoids. In
adults, it has been shown that men have relatively higher
amounts of visceral adipose tissue, as compared to pre-
menopausal women (47), whereas this difference declines
when comparing to postmenopausal women (48). Simi-
larly, prepubertal children have comparable amounts of
visceral adipose tissue (49), whereas peri-/postpubertal
boys have more visceral adipose tissue than peri-/
postpubertal girls (50), as well as hepatic steatosis (22).
Also, it has been shown that increased amounts of
visceral adipose tissue are strongly associated to
accumulation of hepatic fat (51). Thus, differences in
concentrations of sex steroids and glucocorticoids
could be a likely explanation for the differences be-
tween the sexes regarding the associations of ectopic
fat and MetS.
The difference in pubertal development between the
girls and boys with overweight/obesity makes it difficult
to compare the two sexes as pubertal development may
influence the accumulation of hepatic fat (22). However,
we have tried to account for this by adjusting our analyses
for pubertal development. Another limitation is the fact
that the children with overweight/obesity at the point of
examination in the present study had recently been en-
rolled in an obesity treatment programme, which may
have altered their lifestyle, and thereby influenced their
biochemical variables. The group of control children was
relatively small as compared to the group of children
and adolescents with overweight/obesity. Finally, all sta-
tistical analyses were performed without adjusting for
multiple comparisons, which increases the risk of type I
errors.
A strength of the present study is the use of MRS in the
quantification of ectopic fat, as this is considered a reli-
able method with high sensitivity and specificity for eval-
uating fat content in various tissues (41). Ultrasound is
another often used method of measuring hepatic fat;
however, in a study by Mehta et al. (41), which compared
the efficacy of ultrasound and MRS at measuring hepatic
fat content in 50 adults, 44% of the individuals with ab-
sent hepatic fat measured by ultrasound had in fact he-
patic fat accumulation measured by MRS.
A further strength is the inclusion of a relatively large
group of children and adolescents enabling us to analyse
relationships between girls and boys in terms of develop-
ment of MetS and distribution of ectopic fat accumulation.
In conclusion, we found that hepatic and muscular
steatoses, both individually and simultaneously present,
are associated with MetS in girls but not in boys with
overweight/obesity. These results persisted even after
stratifying the population by age. This knowledge may
contribute to a better understanding of the mechanisms
underlying the development of MetS in childhood and its
relation to ectopic lipid accumulation, an understanding
that potentially could improve the treatment of MetS
and steatoses in children and adolescents with
overweight/obesity in daily clinical practice.
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